The NHS is failing those with rare genetic conditions, leaving them with inadequate care and a lack of access to treatments. According to a report, millions of people in the UK are being "systematically ignored" by the NHS, despite the fact that one in 17 people are affected by a rare condition at some point during their lives. The research, published by the charity Genetic Alliance UK, surveyed 290 people living with a rare condition about their experience with the healthcare system. The findings are alarming, to say the least. One in four people had to wait at least three years for a diagnosis despite actively seeking NHS care, while only one in 10 adults had a professional care coordinator to help manage appointments and follow-ups. But here's where it gets controversial... The report also identified an "access lottery" for treatments, meaning that only 5% of rare conditions have treatment available that has been approved and licensed. This is a serious issue, as it means that many people with rare genetic conditions are not receiving the care and treatment they need. For example, Ali Reed's daughter, Emma, has Williams syndrome, which affects about one in 18,000 people across the UK. The condition, caused by an issue with chromosomes, can result in delayed development for children, mild to moderate learning disabilities and an increased risk of cardiovascular disease. Reed said it wasn’t until Emma was nine months old that healthcare professionals questioned her development, and it was a further year before she was diagnosed. This is a stark reminder of the challenges faced by those with rare genetic conditions. The NHS needs to do more to ensure that people with rare conditions receive the care and support they need. Nick Meade, the chief executive of Genetic Alliance UK, said the NHS in some cases was ill-equipped to provide care for people living with rare genetic conditions. He added: "In the main, the NHS does an excellent job of looking after us when we need it, but this isn’t true for everyone. In fact, for those of us living in the UK with a rare condition, it can be quite the reverse." This is a thought-provoking statement, and it raises important questions about the accessibility and quality of care for those with rare genetic conditions. What do you think? Do you agree with Meade's statement? Or do you have a different perspective on the issue? Share your thoughts in the comments below.
